Agios Pharmaceuticals
AGIO
#5097
Rank
โ‚น143.76 B
Marketcap
โ‚น2,465
Share price
-0.87%
Change (1 day)
-33.01%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -โ‚น41.12 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น44.79 Million. In 2024 the company made an earning of -โ‚น38.56 Billion a decrease over its 2023 earnings that were of -โ‚น35.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น41.12 Billion6.62%
2024 -โ‚น38.56 Billion8.75%
2023 -โ‚น35.46 Billion0.63%
2022 -โ‚น35.24 Billion2.81%
2021 -โ‚น34.28 Billion10.58%
2020 -โ‚น31 Billion-18.41%
2019 -โ‚น38 Billion15.72%
2018 -โ‚น32.83 Billion12.99%
2017 -โ‚น29.06 Billion59.61%
2016 -โ‚น18.21 Billion69.32%
2015 -โ‚น10.76 Billion119.28%
2014 -โ‚น4.91 Billion39.22%
2013 -โ‚น3.53 Billion69.1%
2012 -โ‚น2.09 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Xencor
XNCR
-โ‚น12.5 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น79.09 B-283.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.073 T-2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น61.52 B-242.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น844.37 B-2,060.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
โ‚น2.038 T-4,831.71%๐Ÿ‡บ๐Ÿ‡ธ USA